XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.2
Redeemable Noncontrolling Interest (Tables)
 6 Months Ended
Jun. 30, 2025
Noncontrolling Interest [Abstract]  
Summary of company and transfers to noncontrolling interest The following is a summary of net income attributable to the Company and transfers to noncontrolling interest (in thousands):

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net loss available to Class A common stockholders

$

(16,552

)

 

$

(12,506

)

 

$

(33,286

)

 

$

(21,998

)

(Increase)/Decrease in ProKidney Corp. accumulated deficit for impact of
   subsidiary equity-based compensation

 

722

 

 

 

1,374

 

 

 

1,539

 

 

 

3,014

 

(Increase)/Decrease in ProKidney Corp. additional paid-in capital for exchange
   of Common Units in ProKidney LP for Class A common stock

 

(2,834

)

 

 

(12,613

)

 

 

(5,252

)

 

 

(14,902

)

(Increase)/Decrease in ProKidney Corp. additional paid-in capital for vesting of
   Restricted Common Units in ProKidney LP

 

(3,997

)

 

 

22,745

 

 

 

(9,170

)

 

 

14,073

 

Change from net loss available to Class A common stockholders and change
   in ownership interest in ProKidney LP

$

(22,661

)

 

$

(1,000

)

 

$

(46,169

)

 

$

(19,813

)